Osteoporosis Drug May Prevent Spinal Damage, Offering New Back Pain Treatments

New research from the University of Edinburgh, published via ScienceDaily, suggests that genetic changes contribute to spinal disc hardening and deterioration. A study using zebrafish found that an existing osteoporosis drug and targeting fat metabolism could reduce this damage. This discovery points to potential new treatment avenues for spinal disc degeneration and chronic back pain.